04 . 12 .2025
Press release
Galderma secures ‘BBB’ credit rating with positive outlook from S&P Global Ratings
17 . 11 .2025
Press release
ASDS 2025: Compelling new data on Restylane, Sculptra and Relfydess highlight Galderma’s innovative Injectable Aesthetics portfolio and pipeline
05 . 11 .2025
Press release
Galderma receives U.S. FDA approval for Restylane® Lyft™ for the enhancement of the chin profile
24 . 09 .2025
Press release
AMWC Dubai: Galderma demonstrates Injectable Aesthetics leadership through updates on its scientific innovations and community education
18 . 09 .2025
Press release
Galderma launches transformative skincare segment with Cetaphil’s new Skin Activator Hydrating & Firming Line, in partnership with actor and filmmaker Mariska Hargitay
17 . 09 .2025
Press release
Galderma’s groundbreaking real-world study reveals the biological toll of modern living and urban environments on sensitive skin
11 . 09 .2025
Press release
EADV 2025: Galderma reinforces leadership in dermatology with latest advances in sensitive skin and itch
10 . 09 .2025
Press release
Galderma launches Alastin® in China, supporting the skin’s natural regenerative abilities in a rapidly expanding market
17 . 07 .2025
Press release
Galderma unveils final nine-month data showing lasting efficacy and patient satisfaction with its Injectable Aesthetics portfolio when addressing facial aesthetic changes after medication-driven weight loss